Drugs / leukotriene D4
leukotriene D4
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02574975 | Apr 2015 → May 2016 | asthma | Zhujiang Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01963741 | Nov 2012 → Feb 2014 | allergic rhinitis, asthma | Guangzhou Institute of Respiratory Disease | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | leukotriene D4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01963741 ↗ |
| Known as | Leukotriene d | ChEMBL registry synonym — accepted as the source's own label CHEMBL288943 ↗ |
| Known as | LTD4 | “The aim of the present study was to establish the methodology and investigate the diagnostic value and safety of a leukotriene D4 (LTD4) nasal provocation test.” PMID 27347089 ↗ May 2016 |
| Modality | Small molecule | — CHEMBL288943 ↗ |
| Route | Intranasal | “Nasal provocation test induced by LTD4 will be conducted by measuring nasal airway resistance and airway symptoms in a stepwise concentration of LTD4 by nasal spray.” NCT01963741 ↗ |